Follow
Morteza Akbari
Morteza Akbari
Verified email at tbzmed.ac.ir
Title
Cited by
Cited by
Year
Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ...
The Lancet Neurology 23 (4), 344-381, 2024
2262024
Innate and adaptive immune responses against coronavirus
A Hosseini, V Hashemi, N Shomali, F Asghari, T Gharibi, M Akbari, ...
Biomedicine & pharmacotherapy 132, 110859, 2020
1782020
Colon cancer therapy by focusing on colon cancer stem cells and their tumor microenvironment
Z Jahanafrooz, J Mosafer, M Akbari, M Hashemzaei, A Mokhtarzadeh, ...
Journal of cellular physiology 235 (5), 4153-4166, 2020
1392020
CD133: An emerging prognostic factor and therapeutic target in colorectal cancer
M Akbari, N Shomali, A Faraji, D Shanehbandi, M Asadi, A Mokhtarzadeh, ...
Cell biology international 44 (2), 368-380, 2020
512020
Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: a groundbreaking cell-free approach
H Yari, MV Mikhailova, M Mardasi, M Jafarzadehgharehziaaddin, ...
Stem cell research & therapy 13 (1), 423, 2022
502022
Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; combination of oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction
A Mardi, AV Shirokova, RN Mohammed, A Keshavarz, AO Zekiy, ...
Cancer Cell International 22 (1), 168, 2022
492022
miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4
MRMH Azar, H Aghazadeh, HN Mohammed, MRS Sara, A Hosseini, ...
International immunopharmacology 92, 107355, 2021
462021
A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
RN Mohammed, R Tamjidifar, HS Rahman, A Adili, S Ghoreishizadeh, ...
Cell Communication and Signaling 20 (1), 79, 2022
432022
Harmful effects of high amounts of glucose on the immune system: An updated review
N Shomali, J Mahmoudi, A Mahmoodpoor, RE Zamiri, M Akbari, H Xu, ...
Biotechnology and applied biochemistry 68 (2), 404-410, 2021
422021
Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy
F Marofi, HS Rahman, L Thangavelu, A Dorofeev, F Bayas-Morejón, ...
Stem cell research & therapy 12, 1-21, 2021
402021
miR‐143 acts as an inhibitor of migration and proliferation as well as an inducer of apoptosis in melanoma cancer cells in vitro
SA Nabipoorashrafi, N Shomali, L Sadat‐Hatamnezhad, ...
IUBMB life 72 (9), 2034-2044, 2020
382020
Dysregulated microRNAs in colorectal carcinogenesis: new insight to cell survival and apoptosis regulation
A Anvarnia, F Mohaddes‐Gharamaleki, M Asadi, M Akbari, B Yousefi, ...
Journal of cellular physiology 234 (12), 21683-21693, 2019
382019
The Improvement of Production Profile While Managing Reservoir Uncertainties with Inflow Control Devices Completions
M MoradiDowlatabad, F Zarei, M Akbari
SPE Norway Subsurface Conference?, SPE-173841-MS, 2015
332015
Major depressive disorder: Biomarkers and biosensors
M Dadkhah, M Jafarzadehgharehziaaddin, S Molaei, M Akbari, ...
Clinica Chimica Acta 547, 117437, 2023
272023
Advances in siRNA delivery approaches in cancer therapy: challenges and opportunities
H Isazadeh, F Oruji, S Shabani, J Behroozi, H Nasiri, A Isazadeh, ...
Molecular Biology Reports 50 (11), 9529-9543, 2023
252023
Introducing a novel beta-ray sensor based on polycarbonate/bismuth oxide nanocomposite
SM Safdari, S Malekie, S Kashian, M Akbari
Scientific Reports 12 (1), 2496, 2022
252022
New immunotherapeutic approaches for cancer treatment
A Kamrani, R Hosseinzadeh, N Shomali, JA Heris, P Shahabi, ...
Pathology-Research and Practice 248, 154632, 2023
212023
Prognostic and diagnostic values of miR-506 and SPON 1 in colorectal cancer with clinicopathological considerations
R Tamjidifar, M Akbari, S Tarzi, M Sadeghzadeh, M Abolghasemi, ...
Journal of gastrointestinal cancer 52, 125-129, 2021
212021
MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers
M Sajjadi-Dokht, TAM Mohamad, HS Rahman, MS Maashi, S Danshina, ...
Genes & diseases 9 (4), 849-867, 2022
172022
Considerations for optimum inflow control devices (ICDs) selection and placement in horizontal sections
M Akbari, JR Gonzalez, N Macklin
SPE Russian Petroleum Technology Conference?, SPE-171281-MS, 2014
172014
The system can't perform the operation now. Try again later.
Articles 1–20